Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 10, Issue 16, Pages 1885-1905Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612043384420
Keywords
mitogen activated protein kinase; ERK; JNK; p38; signal transduction; drug discovery; clinical trials
Categories
Ask authors/readers for more resources
MAPK (Mitogen Activated Protein Kinase) pathways mediate fundamental biological processes and have moved into the limelight of drug discovery during the past decade. Here we review the biochemistry and biology of MAPK signalling with a focus on ERK, JNK and p38. We summarise current drug discovery efforts and clinical trials. Further, we critically discuss the rationale behind current strategies of using MAPK pathways as drug targets and suggest new approaches that take the complexity of MAPK signalling networks into account.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available